Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ruben A. Saez"'
Autor:
Ruben Vicente-Saez
Publikováno v:
Aalto University
RODERIC. Repositorio Institucional de la Universitat de Valéncia
instname
RODERIC. Repositorio Institucional de la Universitat de Valéncia
instname
Advances in digital technologies have disrupted the established openness of the institution of open science in the digital era. They have introduced unprecedented possibilities and challenges to instantly, interactively, collaboratively, and responsi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::48c7bd701e507d3a3058e66bca3be83a
https://hdl.handle.net/10550/80738
https://hdl.handle.net/10550/80738
Publikováno v:
Journal of Business Research. 88:428-436
Open Science is a disruptive phenomenon that is emerging around the world and especially in Europe. Open Science brings about socio-cultural and technological change, based on openness and connectivity, on how research is designed, performed, capture
Autor:
Ruben A. Saez
Publikováno v:
Cancer Control. 4:399-406
BackgroundThe treatment of acute myelogenous leukemia has evolved in recent years due to advances in supportive care, the identification of prognostic factors, and the careful evaluation of chemotherapeutic modalities in randomized clinical trials.Me
Autor:
Ruben A. Saez, S. F. Williams, B. E. Hillner, W. P. Vaughan, M. J. Kennedy, J. W. Fay, Edward A. Stadtmauer, Corey J. Pelz, Kathleen A. Sobocinski, Hillard M. Lazarus, Robert Peter Gale, S. Wolff, Mary M. Horowitz, John P. Klein, Philip A. Rowlings, Philip L. McCarthy, K. K. Fields, H. K. Holland, Karen H. Antman, James O. Armitage, G. Spitzer, C. O. Freytes
Publikováno v:
Journal of Clinical Oncology. 15:1870-1879
PURPOSE To identify trends in high-dose therapy with autologous hematopoietic stem-cell support (autotransplants) for breast cancer (1989 to 1995). PATIENTS AND METHODS Analysis of patients who received autotransplants and were reported to the Autolo
Autor:
Lary A. Robinson, Ramon L. Sandin, Carlos A. Muro-Cacho, Deborah Foster, Ruben A. Saez, G. V. Venkattaramanabalaji, John N. Greene
Publikováno v:
Cancer Control. 4:168-171
Autor:
L. Pineiro, Joseph DiCesare, Marilyn Campion, James M. Felser, Ruben A. Saez, Roger H. Herzig, Joseph W. Fay, Brenda W. Cooper, Geoffrey P. Herzig, Hillard M. Lazarus, Robert H. Collins, Don A. Stevens, Steven H. Bernstein
Publikováno v:
Blood. 84:2151-2157
Preclinical studies of recombinant human interleukin-3 (rhIL-3) and granulocyte-macrophage colony-stimulating factor (rhGM-CSF) have shown enhancement of multilineage hematopoiesis when administered sequentially. This study was designed to evaluate t
Autor:
J Gibson, Robert Wesolowski, F de Snoo, Eli Avisar, Ruben A. Saez, Charles E. Cox, Peter W. Blumencranz, Lisette Stork-Sloots
Publikováno v:
Cancer Research. 73:OT1-2
Background: Women with locally advanced breast cancer (LABC) are often treated with neo-adjuvant chemotherapy to reduce the size of the tumor prior to surgery, to enable breast conserving surgery and to observe the clinical effect of therapy in real
Autor:
Eric L. Raefsky, Elizabeth R. Vazquez, F. Anthony Greco, David R. Spigel, James D. Bearden, John D. Hainsworth, Ruben A. Saez
Publikováno v:
Cancer. 112(6)
BACKGROUND The purpose of the current study was to evaluate the efficacy and toxicity of the combination of fludarabine and rituximab, followed by alemtuzumab, as first-line treatment for patients with chronic lymphocytic leukemia (CLL) or small lymp
Autor:
Ruben A. Saez, Robert Wesolowski, William C. Dooley, Eli Avisar, Peter W. Blumencranz, Sarah Untch, Charles E. Cox, Femke A. de Snoo, Lisette Stork-Sloots
Publikováno v:
Cancer Research. 75:OT3-2
Background: Women with locally advanced breast cancer (LABC) are often treated with neo-adjuvant chemotherapy to reduce the size of the tumor prior to surgery, to enable breast conserving surgery and to observe the clinical effect of therapy in real
Autor:
J Gibson, Charles E. Cox, S Glück, Douglas S. Reintgen, Ruben A. Saez, Lisette Stork-Sloots, Peter W. Blumencranz, N Howard
Publikováno v:
Cancer Research. 72:OT3-4
Background: Women with locally advanced breast cancer (LABC) are often treated with neo-adjuvant chemotherapy to reduce the size of the tumor prior to surgery, to enable breast conserving surgery and to observe the clinical effect of therapy in real